MedTrace Logo

Comparison Between Topical Mitomycin C and Cyclosporine

NCT05627947 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2023-10-17

No results posted yet for this study

Summary

Pterygium is a disease associated with proliferation of the fibrovascular tissues of the conjunctiva into the cornea and is related to factors such as ultraviolet light exposure, chronic stimulation, inflammation, climate, and genetics.

Conditions

  • Pterygium

Interventions

DRUG

Mitomycin c

Comparing the effect of Mitomycin C versus Cyclosporine after primary pterygium surgery

Sponsors & Collaborators

  • Egymedicalpedia

    lead INDUSTRY

Principal Investigators

  • Marwa Zaki, Assist.Prof. · Department of ophthalmology Faculty of Medicine, Menoufia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-06-15
Completion
2022-06-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05627947 on ClinicalTrials.gov